Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
Precision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and rad...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2018/4809183 |
id |
doaj-5609b9af9d394f75b62e3058fd4e82ed |
---|---|
record_format |
Article |
spelling |
doaj-5609b9af9d394f75b62e3058fd4e82ed2020-11-25T00:15:18ZengHindawi LimitedInternational Journal of Breast Cancer2090-31702090-31892018-01-01201810.1155/2018/48091834809183Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and TreatmentEleanor E. R. Harris0Department of Radiation Oncology, Case Western Reserve University and University Hospitals, Cleveland, OH, USAPrecision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and radiation therapy, to survivorship and follow-up care. The precision arises from detailed knowledge of the inherent biological propensities of each tumor, rather than generalizing treatment approaches based on phenotypic, or even genotypic, categories. Extensive research is being conducted in multiple disciplines, including radiology, pathology, molecular biology, and surgical, medical, and radiation oncology. Clinical trial design is adapting to the new paradigms and moving away from grouping heterogeneous patient populations into limited treatment comparison arms. This review touches on several areas invested in clinical research. This special issue highlights the specific work of a number of groups working on precision medicine for breast cancer.http://dx.doi.org/10.1155/2018/4809183 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eleanor E. R. Harris |
spellingShingle |
Eleanor E. R. Harris Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment International Journal of Breast Cancer |
author_facet |
Eleanor E. R. Harris |
author_sort |
Eleanor E. R. Harris |
title |
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment |
title_short |
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment |
title_full |
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment |
title_fullStr |
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment |
title_full_unstemmed |
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment |
title_sort |
precision medicine for breast cancer: the paths to truly individualized diagnosis and treatment |
publisher |
Hindawi Limited |
series |
International Journal of Breast Cancer |
issn |
2090-3170 2090-3189 |
publishDate |
2018-01-01 |
description |
Precision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and radiation therapy, to survivorship and follow-up care. The precision arises from detailed knowledge of the inherent biological propensities of each tumor, rather than generalizing treatment approaches based on phenotypic, or even genotypic, categories. Extensive research is being conducted in multiple disciplines, including radiology, pathology, molecular biology, and surgical, medical, and radiation oncology. Clinical trial design is adapting to the new paradigms and moving away from grouping heterogeneous patient populations into limited treatment comparison arms. This review touches on several areas invested in clinical research. This special issue highlights the specific work of a number of groups working on precision medicine for breast cancer. |
url |
http://dx.doi.org/10.1155/2018/4809183 |
work_keys_str_mv |
AT eleanorerharris precisionmedicineforbreastcancerthepathstotrulyindividualizeddiagnosisandtreatment |
_version_ |
1725387711460671488 |